In short
Ivosidenib, also known as AG-120 or Tibsovo, is an innovative drug being studied in various clinical trials for its potential in treating different types of cancer, particularly those with IDH1 mutations. These trials aim to evaluate the drug's effectiveness, safety, and impact on patients' quality of life across different cancer types and treatment scenarios.
At a glance
- Drug Name
- Ivosidenib (AG-120, Tibsovo)
- Mechanism
- Inhibitor of mutant IDH1 protein
- Cancer Types Studied
- AML, cholangiocarcinoma, solid tumors, lymphomas, histiocytic disorders with IDH1 mutations
- Administration
- Oral, typically once daily
- Key Outcomes Measured
- Progression-free survival, overall survival, objective response rate, safety, quality of life
- Trial Phases
- Phase 1 and Phase 2 studies
- Special Populations
- Pediatric patients, Japanese patients, patients with hepatic impairment
- Combination Therapies
- Studied with azacitidine in some trials
- Post-Transplant Use
- Investigated as maintenance therapy after stem cell transplantation
What is Ivosidenib?
Ivosidenib, also known by its brand name TIBSOVO, is a medication used to treat certain types of cancer. It's also referred to as AG-120, AG120, or S95031 in some medical literature. This drug is part of a class of medications called IDH1 inhibitors, which target a specific genetic mutation found in some cancer cells.
How Does Ivosidenib Work?
Ivosidenib works by blocking the activity of a mutated form of the IDH1 enzyme (isocitrate dehydrogenase 1). This enzyme, when mutated, can lead to the overproduction of substances that contribute to the growth of cancer cells. By inhibiting this mutated enzyme, ivosidenib may help slow down or stop the growth of cancer cells.
What Conditions Does Ivosidenib Treat?
Ivosidenib is primarily used to treat several types of cancer that have a specific IDH1 mutation. These include:
- Acute Myeloid Leukemia (AML): A type of blood and bone marrow cancer
- Cholangiocarcinoma: A type of bile duct cancer
- Solid Tumors: Various types of cancers that form solid masses
- Myeloproliferative Neoplasms (MPNs): A group of blood cancers where the bone marrow makes too many blood cells
It's important to note that ivosidenib is specifically used for cancers that have an IDH1 mutation. Your doctor will need to perform genetic testing on your cancer cells to determine if this treatment is appropriate for you.
How is Ivosidenib Administered?
Ivosidenib is taken orally, usually once daily. The typical dose is 500 mg, but your doctor may adjust this based on your specific condition and how you respond to the treatment. It's important to take ivosidenib exactly as prescribed by your healthcare provider.
Some key points about taking ivosidenib:
- It can be taken with or without food
- You should avoid eating grapefruit or drinking grapefruit juice while taking this medication
- It's best to take it at approximately the same time each day
Current Clinical Trials
Ivosidenib is currently being studied in several clinical trials to explore its effectiveness in different scenarios:
- As a maintenance therapy after stem cell transplantation for AML patients
- In combination with other drugs like azacitidine for newly diagnosed AML patients
- For treating advanced solid tumors in children and adolescents
- In combination with ruxolitinib for advanced myeloproliferative neoplasms
Potential Side Effects
Like all medications, ivosidenib can cause side effects. Common side effects may include:
- Fatigue
- Nausea
- Changes in blood cell counts
- Electrolyte imbalances
More serious side effects can occur, such as a condition called differentiation syndrome, which can cause fever, difficulty breathing, and other symptoms. It's crucial to report any new or worsening symptoms to your healthcare provider immediately.
Special Considerations
There are some important factors to consider when taking ivosidenib:
- Drug Interactions: Ivosidenib may interact with other medications. Be sure to inform your doctor about all medications, supplements, and herbal products you're taking.
- Liver Function: Your doctor may need to monitor your liver function while you're taking this medication.
- Pregnancy and Breastfeeding: If you're pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits with your healthcare provider.
- QT Prolongation: Ivosidenib may affect your heart rhythm. Your doctor may perform regular electrocardiograms (ECGs) to monitor this.
Remember, ivosidenib is a powerful medication that should only be used under the close supervision of a healthcare professional. Always follow your doctor's instructions and report any concerns or side effects promptly.